

Automated Chemiluminescence Immunoassay Analyzer
全自动化学发光免疫分析仪
- SKU CLI-0001
- CLIA Analyzers
- CE (to be confirmed)
- ISO 13485 manufacturing (to be confirmed)
- NMPA class II registration (to be confirmed)
Price on request — FOB / CIF quoted per order
Prices depend on configuration, quantity and destination port.
Key specifications
| Throughput | 120–240 tests/h |
|---|---|
| First-result time | 15–30 min |
| Detection | Photomultiplier tube, flash chemiluminescence |
| Separation | Magnetic particle with automatic washing |
| Sample volume | 20–150 µL per test |
| Reagent positions | 24–40 refrigerated positions at 4–10 °C |
By Lab Manufacturers China Technical TeamLast reviewed Standards: ISO 15189, CLSI EP05, CLSI EP15
What is the Automated Chemiluminescence Immunoassay Analyzer?
An automated chemiluminescence immunoassay analyzer performs random-access testing with magnetic bead separation, photomultiplier detection and full reagent management. It suits hospital laboratories that need a broad menu of hormones, cardiac markers and infectious disease assays with walkaway operation.
What is the Automated Chemiluminescence Immunoassay Analyzer?
An automated chemiluminescence immunoassay analyzer performs random-access testing with magnetic bead separation, photomultiplier detection and full reagent management. It suits hospital laboratories that need a broad menu of hormones, cardiac markers and infectious disease assays with walkaway operation.
Overview
The analyzer aspirates sample and reagent into a reaction cuvette or tube, incubates the mixture, captures the immune complex on magnetic particles with a magnet, washes away unbound label and adds trigger solutions. A photomultiplier tube counts the emitted photons and the software reads concentration from a stored master curve adjusted for the reagent lot. Random access means any test combination can run in any order, and STAT samples are inserted ahead of routine work. Typical throughput is 120 to 240 tests per hour with a first result in fifteen to thirty minutes, and onboard refrigerated reagent positions allow several hours of operation. Calibration stability of two to four weeks, two or three levels of control per day, and full traceability of reagent lots and operator actions complete the platform.
How does it work?
In chemiluminescence immunoassay the label is a molecule, often an acridinium ester or a luminol derivative, that emits light when triggered by an oxidant or a catalyst. Capture antibody or antigen is immobilised on magnetic particles, a well or a tube. After sample binding and washing, the labelled detection reagent forms a sandwich or competes with the analyte, and a trigger solution initiates the light-emitting reaction. A photomultiplier tube measures the light flash, which is integrated over a fixed interval, and the signal is converted into concentration using a calibration curve, usually a four-parameter logistic or a master curve with a lot-specific adjustment. Because light emission is measured against a dark background rather than as a difference between two absorbance values, chemiluminescence gives a wider dynamic range and better sensitivity than chromogenic enzyme immunoassay, and magnetic separation simplifies washing and automation.
What are the key features?
- Random access with STAT insertion ahead of routine work
- Magnetic bead separation with automatic washing
- Photomultiplier detection with wide dynamic range
- Onboard refrigerated reagents with lot and expiry tracking
- Stored master curve valid for two to four weeks per lot
- Two or three levels of quality control per working day
What are the technical specifications?
A typical automated chemiluminescence immunoassay analyzer configuration offers throughput of 120–240 tests/h, first-result time of 15–30 min, detection of Photomultiplier tube, flash chemiluminescence, separation of Magnetic particle with automatic washing, sample volume of 20–150 µL per test and reagent positions of 24–40 refrigerated positions at 4–10 °C. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.
Which applications is it used for?
The Automated Chemiluminescence Immunoassay Analyzer is used in hormone and thyroid testing, cardiac marker measurement, infectious disease serology and tumour marker monitoring. Across the wider CLIA Analyzers class, laboratories also deploy it for hormone and fertility testing, cardiac marker measurement in emergency care and tumour marker monitoring.
Which standards and certifications apply?
Relevant standards and methods include ISO 15189, CLSI EP05, CLSI EP15, CLSI EP17, CLSI I/LA20, IEC 61010-1 and IEC 61010-2-101. Certification candidates for this model are CE, ISO 13485 manufacturing and NMPA class II registration; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.
Install the analyzer on a stable bench with controlled temperature and humidity, a grounded power supply and space for reagent and waste containers. Verify performance at installation with precision, linearity and method comparison studies for every assay you will report, following CLSI EP05, EP15 and EP17 where detection limits are relevant. Establish calibration and control intervals per assay and document the curve validity period. Daily work includes checking reagent volumes and waste, running controls and reviewing the calibration status; trigger solutions and wash buffers must be prepared or replaced as specified because deteriorated solutions cause erratic light signals. Replace tubing, syringes and photodetector-related parts on schedule, and treat all samples, controls and liquid waste as biohazardous.
How do I select the right Automated Chemiluminescence Immunoassay Analyzer?
Specify this variant when the laboratory needs a broad immunoassay menu in random access with unattended operation. In the RFQ list the assays you intend to report and confirm their registration on the platform, then ask for throughput and first-result time on a realistic mix, reagent position count, calibration stability and the control material supply arrangement.
How does it compare with other CLIA Analyzers variants?
Select a CLIA analyzer from the assay menu first, because registration of each test with the platform is the decisive constraint, then size throughput from daily and peak-hour demand plus about thirty percent headroom. Check the first-result time for emergency markers such as troponin and beta-hCG, since several platforms need twenty to thirty minutes. Compare sensitivity and linear range for the analytes that matter to your clinical service, the sample volume per test, and the calibration stability, which determines how often curves must be rebuilt. Decide between magnetic bead, coated tube and microplate formats according to menu size and acceptable hands-on time. Confirm onboard reagent capacity, refrigeration, STAT access, carryover control, LIS interface, and the availability of calibrators, controls and service support locally.
Full specifications
| Throughput | 120–240 tests/h |
|---|---|
| First-result time | 15–30 min |
| Detection | Photomultiplier tube, flash chemiluminescence |
| Separation | Magnetic particle with automatic washing |
| Sample volume | 20–150 µL per test |
| Reagent positions | 24–40 refrigerated positions at 4–10 °C |
| Calibration stability | 14–28 days per reagent lot |
| Carryover | < 0.1 % with disposable tips |
| Interfaces | LAN with HL7 or ASTM two-way communication |
Indicative values for this product class. Final specifications are confirmed on the quotation and in the calibration documents supplied with the instrument.
Applications
- Hormone and thyroid testing
- Cardiac marker measurement
- Infectious disease serology
- Tumour marker monitoring
Key features
- Random access with STAT insertion ahead of routine work
- Magnetic bead separation with automatic washing
- Photomultiplier detection with wide dynamic range
- Onboard refrigerated reagents with lot and expiry tracking
- Stored master curve valid for two to four weeks per lot
- Two or three levels of quality control per working day
Frequently asked questions about Automated Chemiluminescence Immunoassay Analyzer
The number of concurrent assays is limited by reagent positions and by incubation capacity, not by the software. Most analyzers handle ten to twenty different assays in one run, and laboratories with larger menus can schedule priorities or add a second reagent carousel if the platform allows.
Typically fifteen to thirty minutes from the time the sample is loaded, but this depends on the assay and on whether a STAT sample can enter the run immediately. Ask the supplier to demonstrate the time for your specific cardiac marker assay under realistic loading conditions.
Many platforms use disposable tips to eliminate carryover of patient material, while others rely on a fixed probe with a stringent wash. Tip-based systems cost more per test but simplify contamination control, which matters for low-concentration analytes such as troponin.
Reagents are stored at 2 to 8 degrees Celsius, either onboard in the refrigerated compartment or in the laboratory refrigerator, and must not be frozen unless the instructions permit it. The analyzer records onboard volume, lot and expiry, and laboratories should keep an inventory record outside the instrument as a safeguard.
Chemiluminescence measures light emission against a dark background, giving a wider measuring range and lower detection limits than the absorbance difference measured in ELISA. It also automates more easily because magnetic separation replaces repeated plate washing, though reagent and instrument costs are usually higher.
Most assays use a stored master curve with a lot-specific calibration that remains valid for two to four weeks, with a full curve required at each new reagent lot or after major maintenance. Daily control results confirm that the calibration remains acceptable, and any shift triggers recalibration before reporting.
At extremely high analyte concentrations both capture and detection antibodies become saturated and the signal falls, which can produce a falsely low result. Most analyzers detect this by diluting and re-measuring samples above a defined concentration or by comparing the reaction rate with expected curve behaviour.
Related models






